Mission-driven venture capital fund of the American Cancer Society
Employees: 11-50
Investment Type: Venture Capital
Portfolio 23
| Date | Name | Website | Total Raised | Location |
| 21.09.2024 | Paradigm | paradigm.inc | $203M | United Sta... |
| 21.09.2024 | Nusano | nusano.com | $115M | United Sta... |
| 21.09.2024 | Sonata The... | sonatatx.com | - | United Sta... |
| 21.09.2024 | Modifi Bio | modifibio.com | $6.7M | - |
| 21.09.2024 | Clasp Ther... | clasptx.com | - | - |
| 05.05.2023 | Mercy BioA... | mercybio.com | $41M | United Sta... |
| 16.02.2023 | Thatch | thatch.ai | $44M | United Sta... |
| - | Cygnal The... | cygnaltx.com | - | - |
| - | Lunit | lunit.io | $237M | South Kore... |
| - | Persephone... | persephonebiosciences.com | $15M | United Sta... |
Show more
Mentions in press and media 5
| Date | Title | Description |
| 26.08.2020 | Freenome Secures $270M Series C To Research Cancer-Detecting Blood Tests | 7 Shares Email Facebook Twitter LinkedIn Biotechnology company Freenome announced its largest funding round to date, an oversubscribed $270 million Series C financing, the company said Wednesday. Subscribe to the Crunchbase Daily The new in... |
| - | American Cancer Society’s Impact Venture Capital Arm Secures $1 Million in New Contributions | For more information, contact: Michele Money-Carson michele.money-carson@cancer.org |
| - | BrightEdge Announces Second Investment in Freenome, Technology Firm Focused on Early Detection for Cancer | BrightEdge, LLC today announced a second investment in Freenome, a San Francisco-based biotechnology company pioneering comprehensive multiomics platform for early detection of cancer through a routine blood draw. BrightEdge announced its i... |
| - | American Cancer Society’s BrightEdge to Invest in Checkmate Pharmaceuticals | BrightEdge, LLC, the American Cancer Society’s philanthropic impact fund, today announced its participation in the Series C funding round of Checkmate Pharmaceuticals (www.checkmatepharma.com), a clinical stage biopharmaceutical company foc... |
| - | BrightEdge, American Cancer Society's Newly Formed Philanthropic Impact Fund, Announces First Investment | ATLANTA, GA and FRIENDSWOOD, TX, April 16, 2019 – BrightEdge Impact Fund, the American Cancer Society’s newly formed philanthropic impact fund, today announced its participation in an $11.6 million convertible note investment in Castle Bios... |